California Public Employees Retirement System cut its position in Analogic Corporation (NASDAQ:ALOG) by 9.4% during the first quarter, according to its most recent filing with the SEC. The fund owned 41,500 shares of the medical research company’s stock after selling 4,300 shares during the period. California Public Employees Retirement System’s holdings in Analogic Corporation were worth $3,150,000 at the end of the most recent quarter.
Several other large investors also recently bought and sold shares of ALOG. SG Americas Securities LLC acquired a new stake in shares of Analogic Corporation during the first quarter worth about $101,000. State of Alaska Department of Revenue boosted its stake in shares of Analogic Corporation by 3.0% in the first quarter. State of Alaska Department of Revenue now owns 1,380 shares of the medical research company’s stock worth $104,000 after buying an additional 40 shares during the last quarter. US Bancorp DE boosted its stake in shares of Analogic Corporation by 59.0% in the first quarter. US Bancorp DE now owns 1,635 shares of the medical research company’s stock worth $124,000 after buying an additional 607 shares during the last quarter. Dubuque Bank & Trust Co. acquired a new stake in shares of Analogic Corporation during the first quarter worth about $185,000. Finally, Municipal Employees Retirement System of Michigan boosted its stake in shares of Analogic Corporation by 2.5% in the first quarter. Municipal Employees Retirement System of Michigan now owns 2,850 shares of the medical research company’s stock worth $216,000 after buying an additional 70 shares during the last quarter.
Analogic Corporation (NASDAQ ALOG) traded down 0.50% on Wednesday, hitting $70.00. 61,255 shares of the stock traded hands. Analogic Corporation has a 52-week low of $66.00 and a 52-week high of $95.85. The stock’s market cap is $872.90 million. The company’s 50 day moving average price is $70.94 and its 200-day moving average price is $73.43.
Analogic Corporation (NASDAQ:ALOG) last announced its quarterly earnings data on Tuesday, June 6th. The medical research company reported $0.79 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.74 by $0.05. The firm had revenue of $122.16 million for the quarter, compared to the consensus estimate of $121.35 million. Analogic Corporation had a negative net margin of 7.97% and a positive return on equity of 6.75%. The company’s revenue was down 4.5% on a year-over-year basis. During the same period last year, the firm earned $0.80 EPS. On average, analysts forecast that Analogic Corporation will post $2.60 earnings per share for the current fiscal year.
Separately, Jefferies Group LLC initiated coverage on shares of Analogic Corporation in a report on Wednesday, August 9th. They set a “hold” rating and a $75.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the company. Analogic Corporation presently has a consensus rating of “Hold” and an average target price of $87.00.
Analogic Corporation Company Profile
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Receive News & Ratings for Analogic Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic Corporation and related companies with our FREE daily email newsletter.